Pathology of breast cancer in women with constitutional CHEK2 mutations

被引:0
|
作者
Tomasz Huzarski
Cezary Cybulski
Wenancjusz Domagała
Jacek Gronwald
Tomasz Byrski
Marek Szwiec
Stanisław Woyke
Steven A Narod
Jan Lubiński
机构
[1] Pomeranian Medical University,The Centre for Research in Women’s Health
[2] Regional Oncology Hospital,International Hereditary Cancer Centre, Department of Genetics and Pathology
[3] University of Toronto,undefined
[4] Pomeranian Medical University,undefined
来源
关键词
breast cancer; CHEK 2; lobular carcinoma; risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
The power of association studies between polymorphic genetic variants and breast cancer may be enhanced if the cancer subjects are subclassified by histologic subgroup. In this study we classified 482 unselected breast cancers from Szczecin, Poland by histology (ductal, lobular, medullary, other). All women were genotyped for three founder mutations in the CHEK2 gene (1100delC, IVS2 + 1G > A and I157T). There was no significant overall association between CHEK2 and breast cancer (OR = 1.3; p = 0.30), but among those with lobular carcinoma the association with the I157T missense mutation was very strong (OR = 6.6; p > 0.0001). This is the first report to demonstrate that different mutations of the same gene may be associated with specific histologic subtypes of cancer.
引用
收藏
页码:187 / 189
页数:2
相关论文
共 50 条
  • [41] Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer
    Detlef K. Bartsch
    Kristina Krysewski
    Mercedes Sina-Frey
    Volker Fendrich
    Harald Rieder
    Peter Langer
    Ralf Kress
    Margarete Schneider
    Stephan A. Hahn
    Emily P. Slater
    Familial Cancer, 2006, 5 : 305 - 308
  • [42] Survival of bladder or renal cancer in patients with CHEK2 mutations
    Zlowocka-Perlowska, Elzbieta
    Debniak, Tadeusz
    Slojewski, Marcin
    van de Wetering, Thierry
    Toloczko-Grabarek, Aleksandra
    Cybulski, Cezary
    Scott, Rodney J.
    Lubinski, Jan
    PLOS ONE, 2021, 16 (09):
  • [43] CHEK2 mutations in primary glioblastomas
    Satu-Leena Sallinen
    TarjaI konen
    Hannu Haapasalo
    Johanna Schleutker
    Journal of Neuro-Oncology, 2005, 74 : 93 - 95
  • [44] CHEK2 mutations in primary glioblastomas
    Sallinen, SL
    Ikonen, T
    Haapasalo, H
    Schleutker, J
    JOURNAL OF NEURO-ONCOLOGY, 2005, 74 (01) : 93 - 95
  • [45] The CHEK2 gene and inherited breast cancer susceptibility
    Nevanlinna, H.
    Bartek, J.
    ONCOGENE, 2006, 25 (43) : 5912 - 5919
  • [46] The CHEK2 gene and inherited breast cancer susceptibility
    H Nevanlinna
    J Bartek
    Oncogene, 2006, 25 : 5912 - 5919
  • [47] CHEK2, breast cancer, and the understanding of clinical utility
    Robson, M.
    CLINICAL GENETICS, 2010, 78 (01) : 8 - 10
  • [48] CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
    Koen, Kortbeek
    Robin, De Putter
    Eline, Naert
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [49] Low frequency of CHEK2 mutations in familial pancreatic cancer
    Bartsch, Detlef K.
    Krysewski, Kristina
    Sina-Frey, Mercedes
    Fendrich, Volker
    Rieder, Harald
    Langer, Peter
    Kress, Ralf
    Schneider, Margarete
    Hahn, Stephan A.
    Slater, Emily P.
    FAMILIAL CANCER, 2006, 5 (04) : 305 - 308
  • [50] CHEK2 mutations and HNPCC-related colorectal cancer
    Suchy, Janina
    Cybulski, Cezary
    Wokolorczyk, Dominika
    Oszurek, Oleg
    Gorski, Bohdan
    Debniak, Tadeusz
    Jakubowska, Anna
    Gronwald, Jacek
    Huzarski, Tomasz
    Byrski, Tomasz
    Dziuba, Ireneusz
    Gogacz, Marek
    Wisniowski, Rafal
    Wandzel, Piotr
    Banaszkiewicz, Zbigniew
    Kurzawski, Grzegorz
    Kladny, Jozef
    Narod, Steven A.
    Lubinski, Jan
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (12) : 3005 - 3009